检索结果-南通市图书馆

Impact of Serum Vascular Endothelial Growth Factor on Prognosis in Patients with Unresectable Hepatocellular Carcinoma after Transarterial Chemoembolization

引用

Chinese Journal of Cancer Research 2012年第1期24卷 36-43页

作者： jian-hai guo Xu Zhu Xiao-ting Li Ren-jie Yang Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education) Department of Interventional TherapyPeking University School of OncologyBeijing Cancer Hospital&InstituteBeijing 100142China

Objective： To investigate the expression level with unresectable hepatocellular carcinoma （HCC） and to assess the impact of serum VEGF as chemoembolization （TACE） treatments. of serum vascular endothelial growth factor （VEGF） in patients and its relationship with the c a predictive factor for HCC nicopathological characteristics, prognosis during transarterial Methods： Serum VEGF levels were measured using enzyme-linked immunosorbent assay （ELISA） in 60 random patients who underwent TACE or transarterial infusion （TAI） for unresectable HCC between May and September 2008 and 12 healthy volunteers were also involved in this study to serve as control. All patients＇ clinicopathological features were retrospectively analyzed. Serum VEGF levels were correlated with clinicopathological features of the HCC patients. The patients＇ survival rates were analyzed with Kaplan-Meier survival curves and compared by the log-rank test. The prognostic significance of serum VEGF levels and factors related to survival rate were evaluated by univariate and multivariate analysis. Results： The median serum VEGF level in the HCC patients was 285 pg/ml （range 14-1,207 pg/ml）, significantly higher than that of healthy controls （P=0.021）. The serum VEGF levels were significantly correlated with platelet counts （r=0.396, P=0.002） but not other clinicopathological features. Patients with serum VEGF level 〉285 pg/ml had worse overall survival compared with those with serum VEGF level 〈285 pg/ml （P=0.002）. By multivariate analysis, the serum VEGF level was a significant prognostic factor. Conclusion： High serum VEGF levels may predict poor prognosis of HCC after TACE. This study highlights the importance of tumor biomarker as a prognostic predictor in TACE therapy for HCC, which has an intrinsic problem of unavailability of histopathological prognostic features.

关键词： Hepatocellular carcinoma Vascular endothelial growth factor TACE ELISA

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery

引用

World Journal of Gastroenterology 2011年第39期17卷 4429-4433页

作者： hai—Feng Liu jian-guo Zhang Jun Li Xiao-Guang Chen Wei-An Wang Department of Gastroenterology General Hospital of Chinese People＇s Armed Police Forces Beijing 100039 China

AIM:To evaluate the efficacy of Stretta procedure with gastroesophageal reflux disease(GERD)based on symptom control,medication changes and oesophagitis ***:Ninety patients with a history of GERD underwent Stretta procedure from June 2007 to March *** patients with GERD diagnosed by the pres-ence of endoscopically evidenced oesophagitis or abnormal esophageal pH *** evaluated GERD-health-related quality of life,satisfaction,medication use and endoscopy at baseline,6,12 mo after *** of the procedure were ***:We found that patients experienced significant changes in symptoms of GERD after Stretta *** onset of GERD symptom relief was less than 2 mo(70.0%)or 2 to 6 mo(16.7%).The mean GERD-HRQL score was 25.6(baseline),7.3(6 mo,P<0.01),and 8.1(12 mo,P<0.01).The mean heartburn scorewas 3.3(baseline),and 1.2(12 mo,P<0.05).The percentage of patients with satisfactory GERD control improved from 31.1%at baseline to 86.7%after treat-ment,and patient satisfaction improved from 1.4 at baseline to 4.0 at 12 mo(P<0.01).Medication usage decreased significantly from 100%of patients on pro-ton pump inhibitors therapy at baseline to 76.7%of patients showing elimination of medications or only as needed use of antacids/H2-RA at 12 *** improvement in endoscopic grade of oesophagitis was seen in 33 of the 41 *** patients had either no erosions or only mild erosive disease(grade A)at 6 ***:The experience with Stretta procedure confirms that it is well tolerated,safe,effective and durable in the treatment of *** Stretta procedure provides the drug-refractory patients with a new mini-mally invasive method.

关键词： Gastroesophageal reflux disease Clinical parameters Stretta procedure Radiofrequency

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer

引用

World Journal of Gastroenterology 2017年第12期23卷 2159-2167页

作者： Hui Xie jian-hai guo Wei-Min An Sheng-Tao Tian hai-Peng Yu Xue-Ling Yang Hua-Ming Wang Zhi guo Department of Interventional Therapy Tianjin Medical University Cancer Institute and HospitalNational Clinical Cancer Research CenterKey Laboratory of Cancer Prevention and Therapy Department of interventional therapy 302 Hospital of People's Liberation Army Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Interventional Therapy DepartmentPeking University Cancer Hospital and Institute Center of radiology 302 Hospital of People’s Liberation Army

AIM The purpose of this study was to evaluate the diagnostic value of trefoil factor family 3(TFF3) for the early detection of colorectal cancer(CC). METHODS Serum TFF3 and carcino-embryonic antigen(CEA) were detected in 527 individuals, including 115 healthy control(HC), 198 colorectal adenoma(CA), and 214 CC individuals in the training group. RESULTS Serum TFF3 showed no significant correlation with age, gender, or tumor location but showed significant correlation with the tumor stage. Serum TFF3 in the CC group was significantly higher than in the HC or CA group. The AUC values of TFF3 for discriminating between HC and CC and between CA and CC were 0.930(0.903, 0.958) and 0.834(0.796, 0.873). A multivariate model combining TFF3 and CEA was built. Compared to TFF3 or CEA alone, the multivariate model showed significant improvement(P < 0.001). For discriminating between HC and CC, HC and early stage CC, HC and advanced stage CC, CA and CC, CA and early stage CC, and CA and advanced stage CC in the training group, the sensitivities were 92.99%, 91.46%, 93.18%, 73.83%, 76.83%, and 81.82%, and the specificities were 91.30%, 91.30%, 93.91%, 88.38%, 77.27%, and 88.38%, respectively. After validation, the sensitivities were 89.39%, 85.71%, 90.79%, 72.73%, 71.43%, and 78.95%, and the specificities were 87.85%, 87.85%, 2.52%, 87.85%, 80.77%, and 87.50%, respectively. CONCLUSION The multivariate diagnostic model that included TFF3 and CEA showed significant improvement over the conventional biomarker CEA and might provide a potential method for the early detection of CC.

关键词： Trefoil factor family 3 Colorectal cancer Colorectal adenoma Multivariate model Diagnostic value

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease

引用

World Journal of Clinical Cases 2021年第36期9卷 11165-11172页

作者： hai-jian guo Feng jiang Chu Chen Jia-Yu Shi Ya-Wen Zhao Department of Cardiology Affiliated Hospital of Nantong UniversityNantong 226001Jiangsu ProvinceChina

BACKGROUND Chronic obstructive pulmonary disease(COPD)is a chronic respiratory disease with worldwide occurrence and high disability and mortality *** occurs mostly in the elderly population with pulmonary heart disease,type II respiratory failure,and other serious *** To investigate the correlation of plasma brain natriuretic peptide(BNP)and platelet parameters with cardiac function and pulmonary hypertension in patients with COPD and pulmonary heart *** From June 2016 to June 2019,52 patients with COPD-pulmonary heart disease(pulmonary heart disease group),30 patients with COPD(COPD group),and 30 healthy individuals(control group)in our hospital were enrolled in the *** pulmonary heart disease group was further divided into subgroups according to cardiac function classification and pulmonary artery *** BNP and platelet parameters were estimated and compared among each group and *** correlation of plasma BNP and platelet parameters with cardiac function classification and pulmonary artery pressure was then *** In the pulmonary heart disease group,the COPD group,and the control group,the levels of plasma BNP,platelet distribution width(PDW),and mean platelet volume(MPV)showed a decreasing trend(P0.05).In the cardiac function grade I,II,III,and IV subgroups,the levels of plasma BNP,PDW,and MPV showed an increasing trend(P<0.05),while a decreasing trend was noted in PLT and PCT levels among the four subgroups(P<0.05).Correlation analysis showed that the levels of plasma BNP,PDW,and MPV in patients with pul

关键词： Chronic obstructive pulmonary disease Pulmonary heart disease Plasma brain natriuretic peptide Platelet parameter Cardiac function Pulmonary hypertension Correlation analysis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients

引用

World Journal of Gastroenterology 2015年第36期21卷 10443-10452页

作者： Song Gao Peng-Jun Zhang jian-hai guo Hui Chen hai-Feng Xu Peng Liu Ren-Jie Yang Xu Zhu Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Interventional Therapy DepartmentPeking University Cancer Hospital & Institute

AIM: To compare the efficacy and safety of chemoem-bolization alone or chemoembolization combined with hepatic arterial infusion chemotherapy(haiC),including oxaliplatin(OXA),5-fluorouracil(5-FU) and folinic acid(CF),in inoperable hepatocellular carcinoma(HCC) without distant metastasis. METHODS: Eighty-four inoperable HCC patients were enrolled. Thirty-ninepatient sunderwent chemoembolization alone,and the other 45 patients underwent chemoembolization + haiC(OXA/5-FU/CF) treatment non-randomly. The progression free survival(PFS),objective response rate(ORR),disease control rate(DCR) and adverse reactions were compared between the two ***: A significant difference in the ORR was observed between the chemoembolization alone and chemoembolization + haiC groups. There was no statistically significant difference in DCR between the two groups. The median PFS(m PFS) showed a significant difference between the two groups. For patients with BCLC stage A/B disease,with or without vessel invasion,the chemoembolization + haiC group showed better m PFS when compared to chemoembolization alone,but no significant difference was found in patients with BCLC stage C disease. The parameter of pain(grade Ⅲ-Ⅳ) in the chemoembolization + haiC group was increased statistically. CONCLUSION: Chemoembolization combined with haiC with OXA/5-FU/CF may be safe and more effective than chemoembolization alone for inoperable HCC patients without distant metastasis.

关键词： Chemoembolization Hepatic arterial infusion chemot

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy

引用

World Journal of Gastrointestinal Oncology 2018年第11期10卷 431-438页

作者： Hang-Yu Zhang jian-hai guo Song Gao Hui Chen Xiao-Dong Wang Peng-Jun Zhang Peng Liu Guang Cao hai-Feng Xu Lin-Zhong Zhu Ren-Jie Yang jian Li Xu Zhu Cancer Biotherapy Centre the First Affiliated Hospital of Zhejiang University Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Interventional Therapy Peking University Cancer Hospital and Institute

AIM To analyze the survival data between patients diagnosed with right-sided primary(RSP) tumors and patients diagnosed with left-sided primary(LSP) tumors after hepatic arterial infusion chemotherapy(haiC) at our *** A retrospective analysis of pretreated metastatic colorectal cancer patients who received haiC from May 2006 to August 2015 was conducted. A Cox proportional hazard regression analysis was used to assess the long-term survival outcomes. The mean and median age of patients was 61 years(range 27-85 years). There were 115 males and 53 females in our *** One hundred sixty-eight patients were enrolled in this study. The overall response rate was 28.9% in LSP patients and 27.3% in RSP patients. The disease control rate was 76.3% in LSP patients and 69.7% in RSP patients. The median overall survival in response to haiC was 16.3 mo in the LSP arm and 9.3 mo in the RSP arm(P = 0.164). The median progression-free survival was 5.7 mo in the LSP arm and 4.2 mo in the RSP arm(P = 0.851).CONCLUSION There was no significant difference in survival between LSP patients and RSP patients after haiC. Further prospective studies are needed to confirm these findings.

关键词： Colorectal cancer Hepatic arterial infusion chemotherapy Primary tumor side Local treatment Hepatic metastasis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma

引用

World Journal of Gastrointestinal Oncology 2020年第6期12卷 663-676页

作者： Bao-jiang Liu Song Gao Xu Zhu jian-hai guo Xin Zhang Hui Chen Xiao-Dong Wang Ren-Jie Yang Department of Interventional Therapy Peking University Cancer Hospital and InstituteKey Laboratory of Carcinogenesis and Translational Research(Ministry of Education)Beijing 100142China

BACKGROUND There is little evidence of combining sorafenib with hepatic arterial infusion chemotherapy(haiC)after transarterial chemoembolization(TACE)for intermediate and advanced hepatocellular carcinoma(HCC).It is important to identify that patients with intermediate and advanced HCC are most likely to benefit from this combination *** To investigate the safety and clinical outcomes of sorafenib combined with haiC with folinic acid,5-fluorouracil(5-FU),and oxaliplatin(FOLFOX)after TACE for intermediate and advanced *** This prospective phase II study enrolled patients with intermediate and advanced HCC who underwent treatment with sorafenib combined with *** patients initially received the standard 400 mg dose of sorafenib twice daily before *** at our institute with intermediate and advanced HCC underwent routine ***,the catheter used for embolization was kept in place in the hepatic artery,and oxaliplatin was intraarterially administered for 6 h,followed by 5-FU for 18 h,and folinic acid was intravenously administered for 2 *** primary endpoints were safety,as evaluated by the Common Terminology and Criteria for Adverse Events version 4.0,and 12-mo progression-free survival(PFS),as analyzed by the Kaplan-Meier *** secondary endpoints,the objective response rate(ORR)was evaluated by the modified Response Evaluation Criteria for Solid Tumors,and survival time[overall survival(OS)]was analyzed by the Kaplan-Meier *** Sixty-six participants at our institute with intermediate and advanced HCC were enrolled in this prospective study(mean age,53.3±11.7 years).Approximately 56.1%of participants had Barcelona Clinic Liver Cancer(BCLC)stage C disease,and 43.9%had BCLC stage B *** ORR was 42.4%.The disease control rate was 87.9%.The grade 3-4 toxicities consisted of thrombocytopenia(4.5%),neutropenia(3.0%),and elevated aspartate aminotransferase(12.2%).Hand-foot skin reaction was also observed(40

关键词： Hepatocellular carcinoma Transcatheter arterial chemoembolization Hepatic arterial infusion chemotherapy Oxaliplatin Fluorouracil Sorafenib

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis

引用

World Journal of Gastroenterology 2017年第8期23卷 1406-1411页

作者： jian-hai guo Hang-Yu Zhang Song Gao Peng-Jun Zhang Xiao-Ting Li Hui Chen Xiao-Dong Wang Xu Zhu Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Department of Interventional therapyPeking University Cancer Hospital and Institute Key Laboratory of Carcinogenesis and Trans-lational Research(Ministry of Education/Beijing) Department of RadiologyPeking University Cancer Hospital and Institute

AIM To evaluate the efficiency and safety of hepatic artery infusion chemotherapy(haiC) using raltitrexed or 5-fluorouracil for colorectal cancer(CRC) liver metastasis(CRCLM).METHODS A retrospective analysis of patients with unresectable CRCLM who failed systemic chemotherapy and were subsequently treated with haiC at our institute from May 2013 to April 2015 was performed. A total of 24 patients were treated with 5-fluorouracil, and 18 patients were treated with raltitrexed. RESULTS The median survival time(MST) from diagnosis of CRC was 40.8 mo in the oxaliplatin plus raltitrexed(TOMOX) arm and 33.5 mo in the oxaliplatin plus 5-fluorouracil(FOLFOX) arm(P = 0.802). MST from first haiC was 20.6 mo in the TOMOX arm and 15.4 mo in the FOLFOX arm(P = 0.734). Median progression-free survival(PFS) from first haiC was 4.9 mo and 6.6 mo, respectively, in the TOMOX arm and FOLFOX arm(P= 0.215). Leukopenia(P = 0.026) was more common in the FOLFOX arm, and hepatic disorder(P = 0.039) was more common in the TOMOX arm. There were no treatment-related deaths in the TOMOX arm and one treatment-related death in the FOLFOX arm. Analysis of prognostic factors indicated that response to haiC was a significant factor related to *** No significant difference in survival was observed between the TOMOX and FOLFOX arms. haiC treatment with either TOMOX or FOLFOX was demonstrated as an efficient and safe alternative choice.

关键词： Liver metastasis Hepatic artery infusion chemotherapy Raltitrexed Colorectal cancer FOLFOX

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma

引用

World Journal of Gastroenterology 2020年第27期26卷 3975-3988页

作者： jian-hai guo Shao-Xing Liu Song Gao Fu-Xin Kou Xin Zhang Di Wu Xiao-Ting Li Hui Chen Xiao-Dong Wang Peng Liu Peng-Jun Zhang hai-Feng Xu Guang Cao Lin-Zhong Zhu Ren-Jie Yang Xu Zhu Department of Interventional Therapy Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing)Peking University Cancer Hospital and InstituteBeijing 100142China Department of Radiology Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing)Peking University Cancer Hospital and InstituteBeijing 100142China

BACKGROUND Transarterial chemoembolization(TACE)and hepatic arterial infusion chemotherapy(haiC)have shown promising local benefits for advanced hepatocellular carcinoma(HCC).S-1,a composite preparation of a 5-fluorouracil prodrug,has proven to be a convenient oral chemotherapeutic agent with definite efficacy against advanced *** To evaluate the efficacy and safety of TACE followed by haiC with or without oral S-1 for treating advanced *** In this single-center,open-label,prospective,randomized controlled trial,117 participants with advanced HCC were randomized to receive TACE followed by oxaliplatin-based haiC either with(TACE/haiC+S-1,n=56)or without(TACE/haiC,n=61)oral S-1 between December 2013 and September *** participants were excluded from final analysis for withdrawing *** primary endpoint was progression-free survival(PFS)and secondary endpoints included overall survival(OS),objective response rate,disease control rate and *** In total,115 participants(100 males and 15 females;mean age,57.7 years±11.9)were *** median PFS and OS were 5.0 mo(0.4–58.6 mo)(95%confidence interval(CI):3.82 to 6.18)vs 4.4 mo(1.1–54.4 mo)(95%CI:2.54 to 6.26;P=0.585)and 8.4 mo(0.4–58.6 mo)(95%CI:6.88 to 9.92)vs 8.3 mo(1.4–54.4 m)(95%CI:5.71 to 10.96;P=0.985)in the TACE/haiC+S-1 and TACE/haiC groups,*** objective response rate and disease control rate were 30.9%vs 18.4%and 72.7%vs 56.7%in the TACE/haiC+S-1 and TACE/haiC groups,*** 3/4 adverse events had a similar frequency in both treatment *** No improvements in tumor response rates,PFS or OS were observed with the addition of S-1 to TACE/haiC in advanced *** treatment regimens had a similar safety profile.

关键词： Hepatocellular carcinoma Advanced Hepatic arterial infusion chemotherapy Transarterial chemoembolization Prognosis Efficacy

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Maintaining moderate levels of hypochlorous acid promotes neural stem cell proliferation and differentiation in the recovery phase of stroke

引用

Neural Regeneration Research 2025年第3期20卷 845-857页

作者： Lin-Yan Huang Yi-De Zhang Jie Chen hai-Di Fan Wan Wang Bin Wang Ju-Yun Ma Peng-Peng Li hai-Wei Pu Xin-Yian guo jian-Gang Shen Su-Hua Qi School of Medical Technology Xuzhou Key Laboratory of Laboratory DiagnosticsXuzhou Medical UniversityXuzhouJiangsu ProvinceChina School of Pharmacy Xuzhou Medical UniversityXuzhouJiangsu ProvinceChina Department of Laboratory Medicine Branch Hospital of Huai’an First People’s HospitalHuai’anJiangsu ProvinceChina Department of Laboratory Medicine the Affiliated Hospital of Xuzhou Medical UniversityXuzhouJiangsu ProvinceChina School of Chinese Medicine The University of Hong KongHong Kong Special Administrative RegionChina

It has been shown clinically that continuous removal of ischemia/reperfusion-induced reactive oxygen species is not conducive to the recovery of late ***,previous studies have shown that excessive increases in hypochlorous acid after stroke can cause severe damage to brain *** previous studies have found that a small amount of hypochlorous acid still exists in the later stage of stroke,but its specific role and mechanism are currently *** simulate stroke in vivo,a middle cerebral artery occlusion rat model was established,with an oxygen-glucose deprivation/reoxygenation model established in vitro to mimic *** found that in the early stage(within 24 hours)of ischemic stroke,neutrophils produced a large amount of hypochlorous acid,while in the recovery phase(10 days after stroke),microglia were activated and produced a small amount of hypochlorous ***,in acute stroke in rats,hypochlorous acid production was prevented using a hypochlorous acid scavenger,taurine,or myeloperoxidase inhibitor,4-aminobenzoic acid *** results showed that high levels of hypochlorous acid(200μM)induced neuronal apoptosis after oxygen/glucose deprivation/***,in the recovery phase of the middle cerebral artery occlusion model,a moderate level of hypochlorous acid promoted the proliferation and differentiation of neural stem cells into neurons and *** suggests that hypochlorous acid plays different roles at different phases of cerebral ischemia/reperfusion *** levels of hypochlorous acid(5 and 100μM)promoted nuclear translocation ofβ-*** transfection of single-site mutation plasmids,we found that hypochlorous acid induced chlorination of theβ-catenin tyrosine 30 residue,which promoted nuclear ***,our study indicates that maintaining low levels of hypochlorous acid plays a key role in the recovery of neurological function.

关键词： cell differentiation cerebral ischemia/reperfusion injury chlorination hypochlorous acid microglia neural stem cell neurogenesis nuclear translocation stroke β-catenin

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：